AstraZeneca Urges Del. Justices To End Nexium Fraud Case
By Jeff Montgomery ( March 2, 2016, 7:30 PM EST) -- An attorney for AstraZeneca Pharmaceuticals told Delaware Supreme Court justices on Wednesday they have no reason to resurrect a 12-year-old class action in which six unions accused the company of consumer fraud for promotions that drove doctors to prescribe the heartburn medicine Nexium instead of cheaper over-the-counter drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.